Qiming & K2VC Double Down on Immunotherapy
02 Jun 2023
US$ 19.00
Qiming Venture Partners (Qiming) has led and made a follow-on investment in the pre-series A plus funding round of LTZ T...
Related Publications
Subscribers’ Weekly for the week ending 26 December 2025...
Listen to Subscribers' Weekly 26 Dec 2025...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.